Ellie Okada

In April 2012, Dr. Ellie Okada relocated permanently to Boston, where she established and incorporated Boston Cancer Policy Institute, a 503(c)3 research institute that focuses on social science research on a systems model of advancing translating discoveries to cancers' and related molecular mutations' therapy and diagnostics for unmet needs. Today, she concentrates all of her efforts on conducting and launching research projects at the Institute. Dr. Ellie Okada has started to conduct the research and has found research subjects in Boston area that can be developed universally. She is very grateful to her supporters, especially to the people of Boston, California, and New York, for helping her achieve her present situation. The ideas espoused by the U.S. summit “Innovate America: Thriving in a World of Challenge and Change” sponsored by the Council on Competitiveness influenced Dr. Ellie Okada’s move to the U.S. Her post-university research activities for both private and government entities, including Nikkei Inc., and Eisai Co., Ltd. have been in line with the council’s philosophy of “innovation.” For example, Dr. Okada’s remarks at the meetings of the Japan’s Council for Science and Technology Policy were consistent with the “intellectual property system for global optimization of innovation efforts” suggested in “Innovate America.” Dr. Ellie Okada has taught at Yokohama National University since 1988, and has taught newly created courses on strategic management and intellectual property at Ph.D. and MBA courses since 2003. Dr. Okada has instructed both doctoral and graduate students in the International Graduate School of Social Sciences. As a part of her role as a professor, she has served as a supervisor to several graduate students who have since become professors themselves. Dr. Okada resigned her tenured, full-professor position in March 2012 in order to open the Boston Cancer Policy Institute.